Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

You're not missing anything. Your confusion was the intent of the question.

The comparator is nothing/placebo/control.

It was an outstanding result and it would be hard to do better in vitro. Now we need to see if that translates into efficacy in treating the disease in humans.

Combining the previous safety across several hundred patients, previous antimicrobal and anti-inflammatory results, and these anti-viral in vitro results should make Brilacidin a very compelling avenue for the government to explore in the fight against COVID.

Go IPIX!